#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia Rett syndrome Infantile apnoea Familial hypertriglyceridaemia Kaposi's sarcoma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Superficial vein thrombosis Chronic kidney disease Autoimmune haemolytic anaemia ROHHAD syndrome Pelizaeus-Merzbacher disease Paroxysmal nocturnal haemoglobinuria Immune thrombocytopenia Myelofibrosis Small intestine leiomyosarcoma More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Trials in Disease Rhabdomyosarcoma Nephrotic syndrome – Diagnostics Mucous membrane pemphigoid – Treatment Pleomorphic leiomyosarcoma – Life with Disease Langerhans cell sarcoma – Basic Information Amyotrophic lateral sclerosis – Treatment Proteus syndrome – Life with Disease Primary immunodeficiency syndrome – Diagnostics Glycogen storage disease type I – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sparsentan Vafidemstat Tenofovir Disoproxil Blu-451 Teplizumab Pegargiminase Mexiletine Luspatercept ZIGAKIBART Fosamprenavir Calcium Cd19-Car_Lenti_Allo Talquetamab LTX-002 SODIUM Lib-01 Monohydrate Avibactam Sodium Promazine Hydrochloride Itraconazole Tipiracil Hydrochloride Octocog Alfa CILOSTAZOL More therapies…

    Learn about Your Condition

    Pterygium Oedema peripheral Thrombectomy Pulmonary sarcoidosis Precocious puberty Pancreatic carcinoma recurrent Exposure via breast milk Reperfusion injury Interstitial lung disease Carcinoid syndrome Supranuclear palsy Neurogenic bladder Mitochondrial myopathy Ulcerative keratitis Acute respiratory failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian cancer

  • A Study of Carboplatin Given Directly into the Abdomen After Surgery in Elderly and Frail Patients with Ovarian Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    Denmark

  • A Study of Mirvetuximab Soravtansine, Carboplatin, and Bevacizumab in Adults with Ovarian Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Bevacizumab
    • Carboplatin
    Belgium Czechia Denmark France Spain

  • A Study of INCB123667 in Patients With Platinum-Resistant Ovarian Cancer That Has High Levels of Cyclin E1 Protein

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • INCB123667
    Belgium Spain

  • A Study of Zanidatamab for Patients with Previously Treated HER2-Expressing Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Zanidatamab
    Spain

  • Study of MK-5684 compared to standard therapy in patients with breast cancer, ovarian cancer, or endometrial cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Ovarian cancer
    • Breast cancer
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Hydrocortisone Acetate
    • Medroxyprogesterone Acetate
    Spain

  • Study of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Trastuzumab Deruxtecan
    Austria Belgium Bulgaria Czechia Denmark France +8
Previous Page
1 2 3 4 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!